OM:BONEXBiotechs
Evaluating Bonesupport Holding (OM:BONEX) Valuation Following Strong Clinical Results for CERAMENT® G in Hip Infection Study
For investors keeping an eye on Bonesupport Holding (OM:BONEX), the latest news might feel like a pivotal moment. The company just announced positive clinical data for its CERAMENT® G product, which showed significantly improved patient outcomes in a high-risk hip infection population. What stands out is that not a single patient experienced a re-infection during the two-year follow-up. This is an impressive departure from much higher industry averages and could be a potential signal that...